Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Avery Dennison price target raised to $241 from $200 at BMO Capital » 07:22
04/30/21
04/30
07:22
04/30/21
07:22
AVY

Avery Dennison

$214.64 /

+3.28 (+1.55%)

BMO Capital analyst John…

BMO Capital analyst John McNulty raised the firm's price target on Avery Dennison to $241 from $200 and keeps an Outperform rating on the shares. The company posted a "solid" Q1 earnings beat despite the supply disruptions, rising raw material costs, and customer production issues, the analyst tells investors in a research note. Investor appreciation continues to grow for this "serial compounder", McNulty adds, forecasting "solid upside ahead".

ShowHide Related Items >><<
AVY Avery Dennison
$214.64 /

+3.28 (+1.55%)

AVY Avery Dennison
$214.64 /

+3.28 (+1.55%)

04/29/21
Fly Intel: Top five analyst downgrades
04/29/21 Baird
Avery Dennison price target raised to $250 from $200 at Baird
04/29/21 Citi
Avery Dennison price target raised to $243 from $219 at Citi
04/29/21 UBS
Avery Dennison downgraded to Neutral from Buy at UBS
AVY Avery Dennison
$214.64 /

+3.28 (+1.55%)

AVY Avery Dennison
$214.64 /

+3.28 (+1.55%)

AVY Avery Dennison
$214.64 /

+3.28 (+1.55%)

Downgrade
Fly Intel: Top five analyst downgrades » 09:52
04/29/21
04/29
09:52
04/29/21
09:52
CREE

Cree

$102.79 /

-9.93 (-8.81%)

, EBAY

eBay

$56.75 /

-5.59 (-8.97%)

, AVY

Avery Dennison

$212.00 /

+0.64 (+0.30%)

, MATX

Matson

$66.16 /

-0.26 (-0.39%)

, ADVM

Adverum Biotechnologies

$4.39 /

-5.75 (-56.71%)

Catch up on today's…

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Cree (CREE) downgraded to Underweight from Neutral at JPMorgan with analyst Paul Coster saying the company reported in-line fiscal Q3 results and issued "mixed" Q4 guidance that "leaves the narrative unchanged but the stock looking a richly-valued." 2. eBay (EBAY) downgraded to Neutral from Positive at Susquehanna and downgraded to Neutral from Outperform at Wedbush. 3. Avery Dennison (AVY) downgraded to Neutral from Buy at UBS with analyst Joshua Spector saying the company should continue to deliver above-GDP organic growth, but the stock is now 65% above pre-pandemic levels with a forward multiple that is 25% higher, making its risk-reward "more balanced" at current levels. 4. Matson (MATX) downgraded to Equal Weight from Overweight at Stephens with analyst Jack Atkins saying while the company has executed "extremely well" over the last 12 months and is coming out of the pandemic as "a stronger company with structurally higher earnings and cash flow," the fact that the stock didn't go up on the "really good" news that was the company's Q1 results is likely "a sign that it is time to move to the sidelines." 5. Adverum Biotechnologies (ADVM) downgraded to Sector Perform from Outperform at RBC Capital and downgraded to Hold from Buy at Truist. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
EBAY eBay
$56.75 /

-5.59 (-8.97%)

CREE Cree
$102.79 /

-9.93 (-8.81%)

AVY Avery Dennison
$212.00 /

+0.64 (+0.30%)

ADVM Adverum Biotechnologies
$4.39 /

-5.75 (-56.71%)

CREE Cree
$102.79 /

-9.93 (-8.81%)

04/29/21 Canaccord
Cree price target raised to $126 from $120 at Canaccord
04/29/21 JPMorgan
JPMorgan downgrades 'richly-valued' Cree to Underweight from Neutral
04/29/21 JPMorgan
Cree downgraded to Underweight from Neutral at JPMorgan
04/09/21 Deutsche Bank
Cree price target raised to $110 from $100 at Deutsche Bank
EBAY eBay
$56.75 /

-5.59 (-8.97%)

04/29/21 Wedbush
eBay downgraded to Neutral at Wedbush on lower visibility into post-COVID GMV
04/29/21 Barclays
eBay price target lowered to $78 from $84 at Barclays
04/29/21 Wedbush
eBay downgraded to Neutral from Outperform at Wedbush
04/29/21 Susquehanna
eBay downgraded with turnaround thesis played out at Susquehanna
AVY Avery Dennison
$212.00 /

+0.64 (+0.30%)

04/29/21 Baird
Avery Dennison price target raised to $250 from $200 at Baird
04/29/21 Citi
Avery Dennison price target raised to $243 from $219 at Citi
04/29/21 UBS
Avery Dennison downgraded to Neutral from Buy at UBS
04/29/21 UBS
Avery Dennison downgraded to Neutral from Buy at UBS
MATX Matson
$66.16 /

-0.26 (-0.39%)

04/29/21 Stephens
Stephens cuts Matson to Equal Weight after muted reaction to 'really good' Q1
04/29/21 Stephens
Matson downgraded to Equal Weight from Overweight at Stephens
02/24/21 Stephens
Matson price target raised to $80 from $70 at Stephens
11/03/20 Stephens
Matson upgraded to Overweight from Equal Weight at Stephens
ADVM Adverum Biotechnologies
$4.39 /

-5.75 (-56.71%)

04/29/21 Truist
Adverum Biotechnologies downgraded to Hold from Buy at Truist
04/29/21 Truist
Adverum Biotechnologies downgraded to Hold from Buy at Truist
04/29/21 RBC Capital
Adverum Biotech cut to Sector Perform at RBC after SUSAR in ADVM-022 trial
04/29/21 RBC Capital
Adverum Biotechnologies downgraded to Sector Perform from Outperform at RBC Capital
MATX Matson
$66.16 /

-0.26 (-0.39%)

EBAY eBay
$56.75 /

-5.59 (-8.97%)

CREE Cree
$102.79 /

-9.93 (-8.81%)

AVY Avery Dennison
$212.00 /

+0.64 (+0.30%)

ADVM Adverum Biotechnologies
$4.39 /

-5.75 (-56.71%)

  • 13
    Aug
EBAY eBay
$56.75 /

-5.59 (-8.97%)

AVY Avery Dennison
$212.00 /

+0.64 (+0.30%)

MATX Matson
$66.16 /

-0.26 (-0.39%)

EBAY eBay
$56.75 /

-5.59 (-8.97%)

CREE Cree
$102.79 /

-9.93 (-8.81%)

ADVM Adverum Biotechnologies
$4.39 /

-5.75 (-56.71%)

EBAY eBay
$56.75 /

-5.59 (-8.97%)

CREE Cree
$102.79 /

-9.93 (-8.81%)

AVY Avery Dennison
$212.00 /

+0.64 (+0.30%)

Recommendations
Avery Dennison price target raised to $250 from $200 at Baird » 07:08
04/29/21
04/29
07:08
04/29/21
07:08
AVY

Avery Dennison

$211.36 /

+7.27 (+3.56%)

Baird analyst Ghansham…

Baird analyst Ghansham Panjabi raised the firm's price target on Avery Dennison to $250 from $200 and keeps an Outperform rating on the shares. The analyst noted the company delivered on execution through multiple points of the economic cycle and now with the end-market matrix aligning favorably, the company is on track towards generating earnings power.

ShowHide Related Items >><<
AVY Avery Dennison
$211.36 /

+7.27 (+3.56%)

AVY Avery Dennison
$211.36 /

+7.27 (+3.56%)

04/29/21 Citi
Avery Dennison price target raised to $243 from $219 at Citi
04/29/21 UBS
Avery Dennison downgraded to Neutral from Buy at UBS
04/29/21 UBS
Avery Dennison downgraded to Neutral from Buy at UBS
04/29/21 JPMorgan
Avery Dennison upgraded to Neutral with $215 target at JPMorgan
AVY Avery Dennison
$211.36 /

+7.27 (+3.56%)

AVY Avery Dennison
$211.36 /

+7.27 (+3.56%)

AVY Avery Dennison
$211.36 /

+7.27 (+3.56%)

Recommendations
Avery Dennison price target raised to $243 from $219 at Citi » 06:30
04/29/21
04/29
06:30
04/29/21
06:30
AVY

Avery Dennison

$211.36 /

+7.27 (+3.56%)

Citi analyst Anthony…

Citi analyst Anthony Pettinari raised the firm's price target on Avery Dennison to $243 from $219 and keeps a Buy rating on the shares following the "large" Q1 beat.

ShowHide Related Items >><<
AVY Avery Dennison
$211.36 /

+7.27 (+3.56%)

AVY Avery Dennison
$211.36 /

+7.27 (+3.56%)

04/29/21 UBS
Avery Dennison downgraded to Neutral from Buy at UBS
04/29/21 UBS
Avery Dennison downgraded to Neutral from Buy at UBS
04/29/21 JPMorgan
Avery Dennison upgraded to Neutral with $215 target at JPMorgan
04/29/21 JPMorgan
Avery Dennison upgraded to Neutral from Underweight at JPMorgan
AVY Avery Dennison
$211.36 /

+7.27 (+3.56%)

AVY Avery Dennison
$211.36 /

+7.27 (+3.56%)

AVY Avery Dennison
$211.36 /

+7.27 (+3.56%)

Downgrade
Avery Dennison downgraded to Neutral from Buy at UBS » 06:22
04/29/21
04/29
06:22
04/29/21
06:22
AVY

Avery Dennison

$211.36 /

+7.27 (+3.56%)

UBS analyst Joshua…

UBS analyst Joshua Spector downgraded Avery Dennison to Neutral from Buy with a price target of $227, up from $202, following its Q1 earnings beat. The company should continue to deliver above-GDP organic growth, but the stock is now 65% above pre-pandemic levels with a forward multiple that is 25% higher, making its risk-reward "more balanced" at current levels, the analyst tells investors in a research note.

ShowHide Related Items >><<
AVY Avery Dennison
$211.36 /

+7.27 (+3.56%)

AVY Avery Dennison
$211.36 /

+7.27 (+3.56%)

04/29/21 UBS
Avery Dennison downgraded to Neutral from Buy at UBS
04/29/21 JPMorgan
Avery Dennison upgraded to Neutral with $215 target at JPMorgan
04/29/21 JPMorgan
Avery Dennison upgraded to Neutral from Underweight at JPMorgan
04/16/21 Loop Capital
Avery Dennison price target raised to $215 from $210 at Loop Capital
AVY Avery Dennison
$211.36 /

+7.27 (+3.56%)

AVY Avery Dennison
$211.36 /

+7.27 (+3.56%)

AVY Avery Dennison
$211.36 /

+7.27 (+3.56%)

Downgrade
Avery Dennison downgraded to Neutral from Buy at UBS » 06:07
04/29/21
04/29
06:07
04/29/21
06:07
AVY

Avery Dennison

$211.36 /

+7.27 (+3.56%)

UBS analyst Joshua…

UBS analyst Joshua Spector downgraded Avery Dennison to Neutral from Buy with a price target of $227, up from $202.

ShowHide Related Items >><<
AVY Avery Dennison
$211.36 /

+7.27 (+3.56%)

AVY Avery Dennison
$211.36 /

+7.27 (+3.56%)

04/29/21 JPMorgan
Avery Dennison upgraded to Neutral with $215 target at JPMorgan
04/29/21 JPMorgan
Avery Dennison upgraded to Neutral from Underweight at JPMorgan
04/16/21 Loop Capital
Avery Dennison price target raised to $215 from $210 at Loop Capital
03/17/21 Atlantic Equities
Avery Dennison downgraded to Neutral from Overweight at Atlantic Equities
AVY Avery Dennison
$211.36 /

+7.27 (+3.56%)

AVY Avery Dennison
$211.36 /

+7.27 (+3.56%)

AVY Avery Dennison
$211.36 /

+7.27 (+3.56%)

Upgrade
Avery Dennison upgraded to Neutral with $215 target at JPMorgan » 06:03
04/29/21
04/29
06:03
04/29/21
06:03
AVY

Avery Dennison

$211.36 /

+7.27 (+3.56%)

JPMorgan analyst Jeffrey…

JPMorgan analyst Jeffrey Zekauskas upgraded Avery Dennison to Neutral from Underweight with a price target of $215, up from $155. Avery's Q1 cash flows were a positive departure from its historical patterns, Zekauskas tells investors in a research note. The company has grown its earnings "nicely" and is now benefiting from the reopening of the global economies, says the analyst. He raised his earnings estimates "substantially" higher for Avery and upgraded the shares.

ShowHide Related Items >><<
AVY Avery Dennison
$211.36 /

+7.27 (+3.56%)

AVY Avery Dennison
$211.36 /

+7.27 (+3.56%)

04/29/21 JPMorgan
Avery Dennison upgraded to Neutral from Underweight at JPMorgan
04/16/21 Loop Capital
Avery Dennison price target raised to $215 from $210 at Loop Capital
03/17/21 Atlantic Equities
Avery Dennison downgraded to Neutral from Overweight at Atlantic Equities
03/11/21 BMO Capital
Avery Dennison price target raised to $200 from $190 at BMO Capital
AVY Avery Dennison
$211.36 /

+7.27 (+3.56%)

AVY Avery Dennison
$211.36 /

+7.27 (+3.56%)

AVY Avery Dennison
$211.36 /

+7.27 (+3.56%)

Upgrade
Avery Dennison upgraded to Neutral from Underweight at JPMorgan » 04:43
04/29/21
04/29
04:43
04/29/21
04:43
AVY

Avery Dennison

$211.36 /

+7.27 (+3.56%)

JPMorgan analyst Jeffrey…

JPMorgan analyst Jeffrey Zekauskas upgraded Avery Dennison to Neutral from Underweight with a $215 price target.

ShowHide Related Items >><<
AVY Avery Dennison
$211.36 /

+7.27 (+3.56%)

AVY Avery Dennison
$211.36 /

+7.27 (+3.56%)

04/16/21 Loop Capital
Avery Dennison price target raised to $215 from $210 at Loop Capital
03/17/21 Atlantic Equities
Avery Dennison downgraded to Neutral from Overweight at Atlantic Equities
03/11/21 BMO Capital
Avery Dennison price target raised to $200 from $190 at BMO Capital
03/11/21 Morgan Stanley
Avery Dennison price target raised to $182 from $174 at Morgan Stanley
AVY Avery Dennison
$211.36 /

+7.27 (+3.56%)

AVY Avery Dennison
$211.36 /

+7.27 (+3.56%)

AVY Avery Dennison
$211.36 /

+7.27 (+3.56%)

Options
Early notable gainers among liquid option names on April 28th » 09:55
04/28/21
04/28
09:55
04/28/21
09:55
GOOGL

Alphabet Class A

$2,384.76 /

+93.84 (+4.10%)

, AVY

Avery Dennison

$209.98 /

+5.89 (+2.89%)

, COF

Capital One

$146.30 /

+7.52 (+5.42%)

, IPG

Interpublic Group

$30.73 /

+0.87 (+2.91%)

, MDLZ

Mondelez

$61.66 /

+2.9 (+4.94%)

Notable gainers among…

Notable gainers among liquid option names this morning include Alphabet Class A (GOOGL) $2421.82 +130.91, Avery Dennison (AVY) $214.66 +10.43, Capital One (COF) $145.93 +6.98, Interpublic Group (IPG) $31.07 +1.23, and Mondelez (MDLZ) $61.20 +2.42.

ShowHide Related Items >><<
MDLZ Mondelez
$61.66 /

+2.9 (+4.94%)

IPG Interpublic Group
$30.73 /

+0.87 (+2.91%)

GOOGL Alphabet Class A
$2,384.76 /

+93.84 (+4.10%)

COF Capital One
$146.30 /

+7.52 (+5.42%)

AVY Avery Dennison
$209.98 /

+5.89 (+2.89%)

GOOGL Alphabet Class A
$2,384.76 /

+93.84 (+4.10%)

04/28/21 Jefferies
Alphabet price target raised to $2,850 from $2,700 at Jefferies
04/28/21 Wedbush
Alphabet price target raised to $3,127 from $2,953 at Wedbush
04/28/21 Oppenheimer
Alphabet price target raised to $2,510 from $2,350 at Oppenheimer
04/28/21 BMO Capital
Alphabet price target raised to $2,700 from $2,600 at BMO Capital
AVY Avery Dennison
$209.98 /

+5.89 (+2.89%)

04/16/21 Loop Capital
Avery Dennison price target raised to $215 from $210 at Loop Capital
03/17/21 Atlantic Equities
Avery Dennison downgraded to Neutral from Overweight at Atlantic Equities
03/11/21 BMO Capital
Avery Dennison price target raised to $200 from $190 at BMO Capital
03/11/21 Morgan Stanley
Avery Dennison price target raised to $182 from $174 at Morgan Stanley
COF Capital One
$146.30 /

+7.52 (+5.42%)

04/28/21 Oppenheimer
Capital One price target raised to $155 from $130 at Oppenheimer
04/28/21 Credit Suisse
Capital One price target raised to $160 from $150 at Credit Suisse
04/28/21 Wells Fargo
Capital One price target raised to $155 from $143 at Wells Fargo
04/28/21 RBC Capital
Capital One price target raised to $155 from $140 at RBC Capital
IPG Interpublic Group
$30.73 /

+0.87 (+2.91%)

04/22/21 BMO Capital
Interpublic Group downgraded to Market Perform from Outperform at BMO Capital
02/19/21 BMO Capital
Interpublic Group price target raised to $28 from $23 at BMO Capital
12/15/20 Citi
Interpublic Group price target raised to $29 from $24 at Citi
12/11/20 Barclays
Interpublic Group initiated with an Overweight at Barclays
MDLZ Mondelez
$61.66 /

+2.9 (+4.94%)

04/28/21 Deutsche Bank
Mondelez price target raised to $70 from $67 at Deutsche Bank
02/16/21 Goldman Sachs
Goldman says Mondelez CAGNY presentation 'lends more credibility' to ambitions
01/22/21 Deutsche Bank
Mondelez price target raised to $66 from $64 at Deutsche Bank
01/12/21 Jefferies
Mondelez price target raised to $66 from $62 at Jefferies
MDLZ Mondelez
$61.66 /

+2.9 (+4.94%)

IPG Interpublic Group
$30.73 /

+0.87 (+2.91%)

GOOGL Alphabet Class A
$2,384.76 /

+93.84 (+4.10%)

COF Capital One
$146.30 /

+7.52 (+5.42%)

AVY Avery Dennison
$209.98 /

+5.89 (+2.89%)

MDLZ Mondelez
$61.66 /

+2.9 (+4.94%)

IPG Interpublic Group
$30.73 /

+0.87 (+2.91%)

GOOGL Alphabet Class A
$2,384.76 /

+93.84 (+4.10%)

AVY Avery Dennison
$209.98 /

+5.89 (+2.89%)

MDLZ Mondelez
$61.66 /

+2.9 (+4.94%)

GOOGL Alphabet Class A
$2,384.76 /

+93.84 (+4.10%)

COF Capital One
$146.30 /

+7.52 (+5.42%)

MDLZ Mondelez
$61.66 /

+2.9 (+4.94%)

GOOGL Alphabet Class A
$2,384.76 /

+93.84 (+4.10%)

COF Capital One
$146.30 /

+7.52 (+5.42%)

Earnings
Avery Dennison raises adjusted 2021 EPS view to $8.40-$8.80 from $7.65-$8.05  06:47
04/28/21
04/28
06:47
04/28/21
06:47
AVY

Avery Dennison

$204.29 /

+3.32 (+1.65%)

Consensus is $8.00.

ShowHide Related Items >><<
AVY Avery Dennison
$204.29 /

+3.32 (+1.65%)

AVY Avery Dennison
$204.29 /

+3.32 (+1.65%)

04/16/21 Loop Capital
Avery Dennison price target raised to $215 from $210 at Loop Capital
03/17/21 Atlantic Equities
Avery Dennison downgraded to Neutral from Overweight at Atlantic Equities
03/11/21 BMO Capital
Avery Dennison price target raised to $200 from $190 at BMO Capital
03/11/21 Morgan Stanley
Avery Dennison price target raised to $182 from $174 at Morgan Stanley
AVY Avery Dennison
$204.29 /

+3.32 (+1.65%)

AVY Avery Dennison
$204.29 /

+3.32 (+1.65%)

AVY Avery Dennison
$204.29 /

+3.32 (+1.65%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.